These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22542036)

  • 1. Cytomegalovirus infection in solid organ transplantation.
    Aguado JM; Navarro D; San Juan R; Castón JJ
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():57-62. PubMed ID: 22542036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infections in transplant patients.
    Ljungman P
    Scand J Infect Dis Suppl; 1996; 100():59-63. PubMed ID: 8860355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV infection after organ transplantation: immunopathological and clinical aspects.
    The TH; Grefte JM; van der Bij W; van Son WJ; van den Berg AP
    Neth J Med; 1994 Dec; 45(6):309-18. PubMed ID: 7838248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cytomegalovirus disease.
    Bailey TC
    Semin Respir Infect; 1993 Sep; 8(3):225-32. PubMed ID: 8016483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
    Stratta RJ; Pietrangeli C; Baillie GM
    Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed onset CMV disease in solid organ transplant recipients.
    Husain S; Pietrangeli CE; Zeevi A
    Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring human cytomegalovirus infection in transplant recipients.
    Baldanti F; Lilleri D; Gerna G
    J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cytomegalovirus infection in solid-organ transplant recipients.
    Murray BM
    Immunol Invest; 1997; 26(1-2):243-55. PubMed ID: 9037627
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
    Paya CV
    Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for managing cytomegalovirus in transplant recipients.
    Razonable RR
    Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus pneumonia in transplant recipients.
    Ison MG; Fishman JA
    Clin Chest Med; 2005 Dec; 26(4):691-705, viii. PubMed ID: 16263406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
    Snydman DR
    Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.
    Martin JM; Danziger-Isakov LA
    Pediatr Transplant; 2011 May; 15(3):229-36. PubMed ID: 21199215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
    Singh N
    Clin Infect Dis; 2005 Mar; 40(5):704-8. PubMed ID: 15714416
    [No Abstract]   [Full Text] [Related]  

  • 18. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
    de la Torre-Cisneros J; Fariñas MC; Castón JJ; Aguado JM; Cantisán S; Carratalá J; Cervera C; Cisneros JM; Cordero E; Crespo-Leiro MG; Fortún J; Frauca E; Gavaldá J; Gil-Vernet S; Gurguí M; Len O; Lumbreras C; Marcos MÁ; Martín-Dávila P; Monforte V; Montejo M; Moreno A; Muñoz P; Navarro D; Pahissa A; Pérez JL; Rodriguez-Bernot A; Rumbao J; San Juan R; Santos F; Varo E; Zurbano F;
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):735-58. PubMed ID: 21925772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection: how to manage it in the immunocompromised transplant recipient?
    Müller GA; Müller CA; Einsele H
    Nephrol Dial Transplant; 1994; 9(1):3-4. PubMed ID: 8177474
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infections with cytomegalovirus in both adults and neonates. Diagnosis, therapy and prophylactic procedures].
    Zawilińska B
    Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):776-80. PubMed ID: 1338123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.